- Home
- CDXS vs TRUE Comparison
CDXS vs TRUE Comparison
Compare CDXS & TRUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- TRUE
- Stock Information
- Founded
- CDXS 2002
- TRUE 2005
- Country
- CDXS United States
- TRUE United States
- Employees
- CDXS N/A
- TRUE N/A
- Industry
- CDXS Major Chemicals
- TRUE Computer Software: Programming Data Processing
- Sector
- CDXS Industrials
- TRUE Technology
- Exchange
- CDXS Nasdaq
- TRUE Nasdaq
- Market Cap
- CDXS 216.6M
- TRUE 175.1M
- IPO Year
- CDXS 2010
- TRUE 2014
- Fundamental
- Price
- CDXS $2.56
- TRUE $1.52
- Analyst Decision
- CDXS Buy
- TRUE Hold
- Analyst Count
- CDXS 2
- TRUE 5
- Target Price
- CDXS $11.00
- TRUE $3.33
- AVG Volume (30 Days)
- CDXS 538.3K
- TRUE 389.6K
- Earning Date
- CDXS 10-30-2025
- TRUE 11-05-2025
- Dividend Yield
- CDXS N/A
- TRUE N/A
- EPS Growth
- CDXS N/A
- TRUE N/A
- EPS
- CDXS N/A
- TRUE N/A
- Revenue
- CDXS $57,164,000.00
- TRUE $184,559,000.00
- Revenue This Year
- CDXS $12.88
- TRUE $8.42
- Revenue Next Year
- CDXS $21.64
- TRUE $5.64
- P/E Ratio
- CDXS N/A
- TRUE N/A
- Revenue Growth
- CDXS N/A
- TRUE 11.66
- 52 Week Low
- CDXS $1.90
- TRUE $1.05
- 52 Week High
- CDXS $6.08
- TRUE $4.62
- Technical
- Relative Strength Index (RSI)
- CDXS 51.47
- TRUE 31.84
- Support Level
- CDXS $2.41
- TRUE $1.67
- Resistance Level
- CDXS $2.73
- TRUE $1.89
- Average True Range (ATR)
- CDXS 0.12
- TRUE 0.14
- MACD
- CDXS 0.03
- TRUE -0.07
- Stochastic Oscillator
- CDXS 55.26
- TRUE 0.00
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About TRUE TrueCar Inc.
TrueCar Inc is a data-driven online platform operating on common technology infrastructure, powered by proprietary data and analytics. It also customizes and operates its platform for affinity group marketing partners, including financial institutions like PenFed and American Express; membership-based organizations like Consumer Reports, AARP, Sam's Club, and AAA; and employee buying programs for large enterprises such as IBM and Walmart. The Company has one operating segment, with three distinct service offerings: Dealer products and services, OEM incentives, and other.